DJIA 17,598.20 -91.66 -0.52%
NASDAQ 5,115.38 -12.90 -0.25%
S&P 500 2,098.04 -5.80 -0.28%
market minute promo

48.19 -0.62 (-1.27%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ACAD $48.19 -1.27%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.80
Previous Close $48.81
Daily Range $47.35 - $49.25
52-Week Range $19.67 - $51.99
Market Cap $4.8B
P/E Ratio -42.08
Dividend (Yield) $0.00 (0.0%)
Volume 629,604
Average Daily Volume 1,044,366
Current FY EPS -$1.35




Drug Makers

ACADIA Pharmaceuticals, Inc. (ACAD) Description

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. Website:

News & Commentary Rss Feed

3 Common Pitfalls Biotech Investors Need to Learn to Avoid

Here is a look at three common mistakes investors make when buying biotech stocks.

ACADIA Pharmaceuticals: Developing Late-Stage Assets With Blockbuster Potential

XLF, UBIO: Big ETF Inflows

Commit To Buy Acadia Pharmaceuticals At $32, Earn 13.8% Using Options

Notable ETF Outflow Detected - BIB, ACAD, XLRN, ACRX

ACADIA Pharmaceuticals: If I'm Right, If I'm Wrong

ACADIA Pharmaceuticals (ACAD) Strong On High Relative Volume Today

Insiders Love These 3 Biotech Stocks

These three biotech stocks have big inside ownership, which means their management has a lot of financial incentive to make the company succeed.

Andreas Halvorsen Increases Stake in Esperion Therapeutics

ACADIA Pharmaceuticals Is Poised To Outperform The IBB Moving Forward

See More ACAD News...

ACAD's Top Competitors

ACAD $48.19 (-1.27%)
Current stock: ACAD
AMGN $175.59 (-0.57%)
Current stock: AMGN
GILD $119.60 (1.48%)
Current stock: GILD
BIIB $324.38 (1.76%)
Current stock: BIIB